The Reagan-Udall Foundation opened a Stakeholder Portal on September 16, 2022, to collect perspectives and experiences with the U.S. Food and Drug Administration’s (FDA's) human foods program. In addition, the Foundation announced a public meeting of its food-focused Independent Expert Panel.
The FDA has launched an initiative warning about over-the-counter skin lightening products after receiving reports of side effects.
The agency's Skin Facts! Initiative, announced last week, is aimed at promoting safe use of skin care products, urging people to be aware of non-prescription products marketed to lighten or bleach the skin.
The Reagan-Udall Foundation has announced five members of an independent expert panel who will conduct an operational evaluation of the Food and Drug Administration’s human foods program. Dr. Jane Henney, former FDA Commissioner, was named as chair of the panel last month.
In 2021, a record number of Americans – more than 107,000 – died from drug overdoses. While the loss of human life alone is staggering, we know that the effects of the drug overdose crisis are even broader, including enormous individual and societal costs as people and families grapple with substance use disorder (SUD). Due to this unfortunate reality, in 2017 the opioid crisis was determined to be a public health emergency, which to this day is still in effect. Today’s drug overdose crisis is multifaceted and has evolved beyond prescription opioids.
In June, long-simmering criticism of the way the U.S. Food and Drug Administration is handling premarket tobacco product applications (PMTAs) culminated in a public uproar. “The whole regulatory process is becoming surreal now,” wrote Clive Bates, an independent public health and sustainability advocate, on his blog The Counterfactual.
Work is poised to get underway on a somewhat rare internal review by the U.S. Food and Drug Administration (FDA) that could impact how the agency processes new tobacco products and enforces the sale of them by retailers.
The Reagan-Udall Foundation this week announced that Jane Henney, who served as FDA commissioner during the final years of the Clinton administration, will lead the external review of FDA’s foods program.
The CDC isn’t the only federal regulator taking a cold, hard look in the mirror: Food and Drug Administration Commissioner Robert Califf called on the Reagan-Udall Foundation to review two offices within the agency.
The first shipment of naloxone in a new national effort to reverse overdoses arrived somewhat unceremoniously.
When FDA announced last month it had commissioned an outside evaluation of its foods program (as well as tobacco), it was seen by many as a formal, if somewhat tepid, admission that something had gone very wrong at the agency.
“Fundamental questions about the structure, function, funding and leadership need to be addressed,” FDA Commissioner Robert Califf said at the time. Read more
